What Are GLP-1 Medications? A Plain-English Guide

Some links on our site may earn us a commission at no extra cost to you. Learn more.

Unless you’ve been avoiding the internet entirely, you’ve heard the names: Ozempic, Wegovy, Mounjaro, Zepbound. Behind all of them sits a class of medications called GLP-1 receptor agonists — and they’ve reshaped how doctors, patients, and the entire wellness industry talk about weight. This guide explains what GLP-1s actually are, how they work, and what questions to bring to a healthcare provider, without the hype and without the jargon.

GLP-1 is a hormone your body already makes

GLP-1 stands for glucagon-like peptide-1. It’s a hormone your gut releases naturally after you eat. It does several useful things at once: it signals your brain that you’re full, it slows how quickly food leaves your stomach, and it helps your body manage blood sugar by supporting insulin release.

GLP-1 medications mimic that natural hormone, but with staying power. Where your body’s own GLP-1 breaks down in minutes, the medications are engineered to keep working for days — which is why most are taken as a once-weekly injection. The practical effect for many people: less hunger, fewer cravings, smaller portions feeling satisfying, and less of the constant “food noise” in the background of the day.

The names you keep hearing, sorted out

Much of the confusion around GLP-1s comes from the fact that the same active ingredient shows up under different brand names depending on what it’s approved to treat.

• Semaglutide is the active ingredient in Ozempic (approved for type 2 diabetes) and Wegovy (approved for chronic weight management). Same molecule, different branding and dosing.
• Tirzepatide is the active ingredient in Mounjaro (diabetes) and Zepbound (weight management). Tirzepatide is technically a dual-action medication — it activates both GLP-1 and a second gut hormone receptor called GIP, which research suggests may produce stronger average weight loss.
• Compounded semaglutide and tirzepatide are versions of these active ingredients prepared by licensed compounding pharmacies rather than the original manufacturers. They’re usually far cheaper — but they are not FDA-approved products, an important distinction we cover in depth in our compounded vs. brand-name guide.

What the research actually shows

The clinical results behind these medications are the reason for all the attention. In large trials, semaglutide produced average body weight reductions in the range of 12–15% over roughly 68 weeks when combined with diet and exercise changes. A landmark 2022 trial published in the New England Journal of Medicine found tirzepatide produced average reductions of up to 22.5% over 72 weeks at the highest studied dose — among the strongest results ever recorded for a weight loss medication.

Two honest caveats belong right next to those numbers. First, those are averages from clinical trials — individual results vary widely, and some people respond much less. Second, these medications are not a cure. When people stop taking them, appetite typically returns and weight regain is common unless lifestyle changes stick. Any provider being straight with you will say the same thing.

Who is typically eligible?

Prescribing decisions always belong to a licensed clinician, but the general criteria used for weight management prescriptions are fairly consistent across providers: adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, prediabetes, or sleep apnea.

There are also well-established reasons a clinician may say no. Screening typically covers a personal or family history of medullary thyroid carcinoma or MEN2 syndrome, a history of pancreatitis, and pregnancy or breastfeeding, among other factors. This is exactly why a real medical evaluation matters — and why any program that skips meaningful screening is a red flag.

Side effects: common, usually manageable, worth respecting

The most commonly reported side effects are digestive — nausea, constipation, and diarrhea top the list, especially in the early weeks and after dose increases. That’s why clinicians typically start patients at a low dose and increase gradually. Most side effects are mild and improve over time, but serious reactions are possible, and anyone experiencing severe symptoms should contact their provider promptly. Again: this is a conversation for you and a licensed clinician, not a blog.

How people access GLP-1s today

There are three main routes. The traditional path runs through your own doctor and pharmacy, often involving insurance prior-authorization battles for brand-name medications that can retail around $1,000–$1,350 per month without coverage. The second path is telehealth platforms — services like TrimRX, Brightmeds, Wellorithm, and AltRx — that connect you with licensed prescribers online and typically offer compounded medications at a fraction of brand-name cash prices. The third is employer or insurance programs that have started covering these medications directly.

Prices are approximate, current as of publication, and change frequently — confirm the latest price with the retailer before buying.

Each route has real trade-offs in cost, oversight, and medication type. We walk through how the online programs work — step by step, including what to check before giving anyone your card number — in our guide to how telehealth GLP-1 programs work.

GLP-1s are a real tool, not magic — start with your doctor

GLP-1 medications are a legitimate, well-studied tool for weight management — not magic, not a scam, and not a substitute for the fundamentals of nutrition, movement, and sleep. If you’re considering one, your best first step is a conversation with a licensed healthcare provider who can look at your full health picture. Our job here is simpler: to give you clear information and honest comparisons so that conversation starts from an informed place.